As of 2025-09-17, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -7.20. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 85.66 mil USD. Apyx's TTM EBITDA according to its financial statements is -11.89 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.5x - 22.7x | 21.4x |
| Forward P/E multiples | 22.3x - 22.4x | 22.4x |
| Fair Price | (7.15) - (7.19) | (7.02) |
| Upside | -435.5% - -437.6% | -429.6% |
| Date | EV/EBITDA |
| 2025-09-15 | -7.20 |
| 2025-09-12 | -7.11 |
| 2025-09-11 | -6.79 |
| 2025-09-10 | -6.70 |
| 2025-09-09 | -6.98 |
| 2025-09-08 | -6.98 |
| 2025-09-05 | -6.66 |
| 2025-09-04 | -6.95 |
| 2025-09-03 | -6.47 |
| 2025-09-02 | -6.54 |
| 2025-08-29 | -6.76 |
| 2025-08-28 | -6.85 |
| 2025-08-27 | -6.73 |
| 2025-08-26 | -7.05 |
| 2025-08-25 | -6.98 |
| 2025-08-22 | -7.08 |
| 2025-08-21 | -6.98 |
| 2025-08-20 | -6.89 |
| 2025-08-19 | -6.70 |
| 2025-08-18 | -7.24 |
| 2025-08-15 | -7.30 |
| 2025-08-14 | -7.17 |
| 2025-08-13 | -7.90 |
| 2025-08-12 | -7.55 |
| 2025-08-11 | -7.52 |
| 2025-08-08 | -7.36 |
| 2025-08-07 | -6.66 |
| 2025-08-06 | -6.92 |
| 2025-08-05 | -6.50 |
| 2025-08-04 | -6.31 |
| 2025-08-01 | -6.00 |
| 2025-07-31 | -6.50 |
| 2025-07-30 | -6.47 |
| 2025-07-29 | -6.66 |
| 2025-07-28 | -8.13 |
| 2025-07-25 | -8.51 |
| 2025-07-24 | -7.97 |
| 2025-07-23 | -7.68 |
| 2025-07-22 | -7.59 |
| 2025-07-21 | -7.55 |
| 2025-07-18 | -7.62 |
| 2025-07-17 | -7.68 |
| 2025-07-16 | -7.08 |
| 2025-07-15 | -6.95 |
| 2025-07-14 | -6.70 |
| 2025-07-11 | -7.11 |
| 2025-07-10 | -7.30 |
| 2025-07-09 | -7.68 |
| 2025-07-08 | -7.97 |
| 2025-07-07 | -8.64 |